Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction

E. Miró, M. del Cuerpo, F. Navarro, M. Sabate, B. Mirelis, G. Prats

Research output: Contribution to journalArticleResearch

44 Citations (Scopus)
Original languageEnglish
Pages (from-to)535-538
JournalJ. Antimicrobial Chemother.
Volume42
Issue number0
Publication statusPublished - 1 Jan 1998

Cite this